Method Development for the Separation of Therapeutic Proteins (Biopolymers)

Dec 11 2017 - Dec 12 2017

This course gives an extensive training on HPLC (UHPLC) method development for the separation of therapeutic proteins. The fundamentals of reversed-phase (RP), ion-exchange (IEX), hydrophobic interaction (HI) and size-exclusion (SE) chromatography are explained and discussed. Several examples on monoclonal antibodies (mAbs) and related products (such as antibody-drug conjugates /ADCs/) are presented. 

MAbs and related therapeutics currently account for global sales of ≥USD 50 billion and are starting to receive competition from biosimilar incomes. Most pharmaceutical companies have entered the rapidly growing biosimilar market. Therefore, the appropriate and detailed analysis of biopharmaceuticals at different levels (top-down, middle-down and bottom-up) is demanded by the authorities.

Participants will learn the different two- and three-dimensional (3D) optimization models for all the above mentioned chromatographic modes. Fast and efficient method adjustment, transfer and robustness testing are also demonstrated.

+49 30 421 5590

Digital Edition

Chromatography Today - March 2018 Volume 11 Issue 1

March 2018

In This Issue... Articles - Industrial Applications of Offline and Online Comprehensive Gas Chromatography - Improving Workflow in Group-Type GC×GC Analysis of Petrochemicals - Identifi ca...

View all digital editions


China Lab 2018

Mar 27 2018 Guangzhou, China


Apr 10 2018 Munich, Germany


May 13 2018 Riva del Garda, Italy

ASMS Conference

Jun 03 2018 San Diego, CA, USA


Jun 11 2018 Frankfurt, Germany

View all events